October 24, 2008
Sepracor Plans To Put Europe To Sleep
Marlborough-based Sepracor Inc. said it has moved a step closer to marketing its insomnia drug Lunivia in the European Union.
The European Medicines Agency issued an opinion recommending a marketing authorization for the drug, which is sold in the U.S. as Lunesta. Sepracor has an agreement with GlaxoSmithKline for worldwide commercialization of the drug.
WBJ Web Partners
Most Recent
Most Recent
0 Comments